340B Drug Pricing Program

Special Bulletin
Special Bulletin

HRSA Finalizes Rule on Exclusion of Orphan Drugs for Certain Covered Entities Under 340B Program
Yesterday, the Health Resources and Services Administration (HRSA) published its final rule clarifying the Patient Protection and Affordable Care Act (ACA) provision that excludes orphan drugs for purchase under the 340B drug pricing program
Action Alert
Action Alert

Submit Letters to HRSA Outlining Challenges with 340B GPO Notice
Submit Letters to HRSA Outlining Challenges with 340B GPO Notice -- AHA model letter can guide your comments
Subscribe to 340B Drug Pricing Program